University-CT Radiation-Onclgy is categorized under Hospitals in Farmington, CT .
University-CT Radiation-Onclgy was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Debra Litke, Office Manager at the company’s single location by writing to 263 Farmington Avenue, Farmington, Connecticut CT 06032 or by phoning (860) 679-3225. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | University-CT Radiation-Onclgy |
| Contact Person: | Debra Litke, Office Manager |
| Address: | 263 Farmington Avenue, Farmington, Connecticut 06032 |
| Phone Number: | (860) 679-3225 |
| Website Address: | uchc.edu |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6211110 |
| Share This Business: |
University-CT Radiation-Onclgy was started in 0 to provide professional Hospitals under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Debra Litke, Office Manager for inquiries that concern University-CT Radiation-Onclgy by calling the company number (860) 679-3225, as your correspondence is most welcome. Additionally, the physical location of the single location of University-CT Radiation-Onclgy can be found at the coordinates 41.735,-72.79582 as well as the street address 263 Farmington Avenue in Farmington, Connecticut 06032.
For its online presence, you may visit University-CT Radiation-Onclgy’s website at uchc.edu and engage with its social media outlets through on Twitter and on Facebook.